Human milk is considered as the gold standard for infant feeding. Breastfeeding advantages extend beyond the properties of human milk itself. A complex of nutritional, environmental, socioeconomic, psychological as well as genetic interactions establish a massive list of benefits of breastfeeding to the health outcomes of the breastfed infant and to the breastfeeding mother. For this reason, exclusive breastfeeding is recommended for about 6 months and should be continued as long as mutually desired by mother and child. The evidence in the literature on the effect of breastfeeding on health outcomes is based on observational studies due to the fact that it is unethical and practically impossible to randomize children to be breastfed or not. As such, multiple confounders cloud the evidence and one must base conclusions on the accumulating evidence when not contradictory and on the only intervention study, PROBIT (Promotion of Breastfeeding Intervention Trial). This review highlights some of the health outcomes related to breastfeeding such as the prevention of infections, the effect of breastfeeding on neurodevelopmental outcome, obesity, allergy and celiac disease. Available evidence as well as some of the contradictory results is discussed.
discussed in other chapters of this workshop. However, breastfeeding advantages extend beyond the properties of human milk itself, and a complex of nutritional, environmental, socioeconomic, psychological as well as genetic interactions establishes a massive list of benefits of breastfeeding to the health outcomes of the breastfed infant ( table 1 ) .
For this reason, exclusive breastfeeding is recommended for about 6 months [2] and should be continued 'as long as mutually desired by mother and child' [1] . Moreover, breastfeeding provides health benefits to the breastfeeding mother as well ( table 2 ). The multitude of studies and accumulated evidence for the benefits of breastfeeding are largely based on observational studies, an obvious finding due to the fact that it is unethical and practically impossible to conduct a double-blind randomized trial comparing breastfeeding and formula feeding. This opens a large window for confounders to play a role in the observed results. The confounders could be related to the nature of observational studies (usually retrospective, and even if prospective, exposure occurred many years earlier, questioning the current relevance, recall bias and the difficulty to distinguish between exclusive and any breastfeeding). In addition, the inability to properly control for the effects of socioeconomic class, parental education and IQ, nonsmoking, healthier diet, less toxic occupational exposure and generally better quality of life of breastfeeding mothers, causal relation is difficult to establish. Currently, only one prospective study, PROBIT (Promotion of Breastfeeding Intervention Trial) was performed using a cluster randomized design, comparing populations were promotion of breastfeeding was exercised (reaching 43.3% exclusive breastfeeding at 3 months of age) to similar populations where no intervention was practiced (reaching 6.4% exclusive breastfeeding at 3 months of age). In that study [3] , it was possible to assess health outcomes of breastfed to nonbreastfed infants prospectively, but being the only available prospective study, its findings cannot be compared to similar studies in other populations, or studies trying to tackle some of the inevitable confounders and the limitations of PROBIT.
In this review, current knowledge on some of the effects of breastfeeding on health outcome of breastfed full-term infants will be discussed briefly based on the current literature, available meta-analyses and the position statements made by the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) [1] and the American Academy of Pediatrics (AAP) [2] . 
Infections
The effect of breastfeeding on reducing infection rates was chosen to be discussed due to the fact that it is the most important health benefit of breastfeeding [1, 2] . In the recent position statement of the AAP, any breastfeeding reduced the risk of gastroenteritis by 64% and of otitis media by 23% [2] . In that report, exclusive breastfeeding for ≥ 3 or 6 months reduced the risk of having otitis media by 50%, while exclusive breastfeeding for >6 months reduced the risk of upper respiratory tract infection by 63% [2] . Further, in that report, exclusive breastfeeding for ≥ 4 months reduced the risk of lower respiratory tract infection by 72%, with further significant effects of exclusive breastfeeding for >6 months as compared to 4-6 months [2] . In a Cochrane review published in 2012, Kramer and Kakuma [4] explored the effect of exclusive breastfeeding duration on the prevention of infection. Based on their PROBIT, comparing 6-7 to 3-4 months of exclusive breastfeeding, they observed a risk ratio of 0.67 [95% confidence interval (CI) 0.46-0.97] for having an episode of acute gastroenteritis at 12 months of age. Based on the PROBIT cohort and an observational study, they found a reduced risk of hospitalization due to respiratory illness (risk ratio 0.75, 95% CI 0.60-0.94).
Neurodevelopmental Outcome
The effect of breastfeeding on neurodevelopmental outcome was chosen to be discussed as it is one of the intriguing questions that demonstrate our inability to properly study the effects of breastfeeding and elucidate the mechanisms behind its actions. The amount of studies on the subject is enormous and here we highlight some of these: Many publications, usually based on observational studies, demonstrate better neurodevelopment of breastfed infants compared to formula-fed infants [1, 2, 5] .
A meta-analysis conducted by Anderson et al. [6] demonstrated higher cognitive function (3.2 points) for breastfed compared with formula-fed infants, with better scores throughout childhood and adolescence, as well as a positive influence of breastfeeding duration. A larger benefit was observed for low-birthweight infants compared to those born with normal weight [6] . However, in a meta-analysis by Der et al. [7] that controlled for maternal IQ as well as other confounders, the effect was small (0.52 points) and nonsignificant. In the only prospective randomized study, PROBIT, at the age of 6.5 years, the intervention group had significantly higher adjusted outcomes of intelligence scores and teacher's ratings [8] . A prospective cohort study of mother-child pairs (n = 1,312) conducted between 1999 and 2002 and published recently found a 'causal relationship of breastfeeding duration with receptive language and verbal and nonverbal intelligence later in life' [9] . Different conclusions come from a population-based cohort (n = 3,761) study that looked at the association of breastfeeding duration with nonverbal intelligence in children aged 6 years. Although, initially, an association was found between breastfeeding duration and child IQ, with an advantage of 0.32 points (95% CI 0.20-0.44) for each additional month of breastfeeding, the association turned insignificant (0.09 points, 95% CI -0.03 to 0.21) after adjustment for sociodemographic and lifestyle factors and maternal IQ. The authors concluded that 'Our results cannot confirm beneficial effects of breastfeeding on child intelligence' [10] . In addition to the various factors and confounders that may or may not have been taken care for, it is plausible that breastfeeding may have different effects in different populations and that genes may play a role in that interaction. In 2007, Caspi et al. [11] hypothesized that 'Breastfed children attain higher IQ scores than children not fed breast milk, presumably because of the fatty acids uniquely available in breast milk' and showed that 'the association between breastfeeding and IQ is moderated by a genetic variant in FADS2, a gene involved in the genetic control of fatty acid pathways'. In a study in two birth cohorts, specific maternal genotypes were associated with higher IQ (CC and CG) and one genotype (GG) resulted in no difference in IQ between breastfed and nonbreastfed infants [11] . These findings suggested that nutrient-gene interactions play a role in the effect of breastfeeding on IQ levels and that the effect was mediated by the ability of the mother to synthesize long-chain polyunsaturated fatty acids. However, few years later, Steer et al. [12] were unable to replicate these findings, and, in their cohort, children with the GG genotype showed the largest difference in IQ between breastfed and formula-fed infants. Although the findings of both studies leave the question of the importance of the FADS2 polymorphism open, evidence in support of the role of polyunsaturated fatty acids comes from the study by Belfort et al. [9] , where beneficial effects of breastfeeding were observed at 3 years of age in children of mothers who consumed 2 or more servings of fish per week: 0.24 points per month of breastfeeding compared with -0.01 points per month of breastfeeding in breastfed infants of mothers who consumed less than 2 servings of fish per week.
To support the importance of breastfeeding to the developing brain, studies of central nervous system structure show changes in both white and gray matter at adolescence in those who were breastfed as infants compared to those who were exclusively formula fed. Kafouri et al. [13] showed that duration of exclusive breastfeeding was associated with cortical thickness in the superior and inferior parietal lobules. Deoni et al. [14] studied white-matter microstructure in healthy children, 10 months to 4 years of age, and demonstrated that children who were breastfed had, in several brain regions, increased white-matter development as well as positive relationships between white-matter microstructure and breastfeeding duration.
Lastly, from a public health perspective, in a large cohort demonstrating significant positive associations between duration of breastfeeding and intelligence in 2 independent samples of young adults using two different intelligence tests [15] , the major finding was not the higher IQ in adults who were breastfed, rather the finding that breastfeeding reduced the prevalence of adults with low IQ below the level of being socially independent. Thus, even if the effect of breastfeeding is small, the social impact of the effect of breastfeeding on IQ is large.
Obesity
The effects of breastfeeding and formula content, especially protein, on body composition is discussed elsewhere in this workshop. However, from a public health perspective, this health outcome is of paramount importance since breastfeeding can be used as an inexpensive preventive measure. The AAP stated in 2012 that 'although complex factors confound studies of obesity, there is a 15-30% reduction in adolescent and adult obesity rates if any breastfeeding occurred in infancy compared with no breastfeeding' [2] . A recent meta-analysis suggests that breastfeeding is a significant protective factor against obesity in children [16] .
Allergy
Observations on the benefit of breastfeeding in reducing the risk of atopic diseases are available already from a study published in 1936, where a 9-month follow-up of more than 20,000 children found a 7-fold reduction in the incidence of eczema in breastfed infants [17] . Ever since, studies have provided conflicting results, including studies demonstrating a protective effect, no effect and even an increased risk of allergic disorders in breastfed infants [1, 5] . These contradictory results could be explained by confounding factors, including, among many, the inability to control for maternal diet, partial breastfeeding, introduction of solids, inconsistent diagnostic criteria for allergic disease, as well as reverse causality (mothers to high-risk infants may tend to breastfeed) [1] . In the ESPGHAN position paper on breastfeeding (2008) reporting the results of 3 meta-analyses, the WHO meta-analysis did not find any effect while the Dutch and the Agency for Healthcare Research Quality found a 'transient, protective effect of exclusive breastfeeding for at least 4 months on atopic dermatitis, wheezing, and asthma in infancy and early childhood' [1] . The AAP (2012) reported a protective effect of exclusive breastfeeding for 3-4 months in reducing the incidence of clinical asthma, atopic dermatitis and eczema by 27% in a lowrisk population and up to 42% in infants with a positive family history [2] . In the PROBIT cohort, atopic dermatitis occurred in 3.3% of the infants in the experimental group versus 6.3% of those in the control group in the first year of life [18] . However, a follow-up at 6.5 years of age did not find any difference in the risk of having allergic symptoms and diagnoses or positive skin prick tests between the experimental group and the control group [19] . An intriguing finding of PROBIT was that when centers with high prevalence of positive skin prick tests were excluded (three in the experimental group and three in the control group), the risk for positive skin tests was higher in the experimental group for 4 of the 5 antigens [19] . Adding to the confusion, a recent systematic review and meta-analysis found a strong protective association between breastfeeding and asthma at the age 0-2 years, with a diminishing effect later on [20] , while another recent systematic review, evaluating environmental exposure and combined effects, found conflicting results on the protective effect for breastfeeding on asthma [21] .
Celiac Disease as a Model for Autoimmune Disorders
In the 2012 position paper by the AAP, a protective effect of breastfeeding was cited for inflammatory bowel diseases (OR 0.69, 95% CI 0.51-0.94), type 1 diabetes mellitus (OR 0.71, 95% CI 0.54-0.93) and celiac disease (OR 0.48, 95% CI 0.4-0.89) determining that the protective effect of breastfeeding regarding celiac disease is due to the introduction of gluten to the infant's diet while the infant is still being breastfed [2] . This conclusion was based on a meta-analysis of 6 retrospective observational studies (with a large effect of the observational study that analyzed the celiac epidemic in Sweden) that found in 5 of the 6 studies an association between increased duration of breastfeeding and a reduced risk to develop celiac disease [22] . In that meta-analysis, breastfeeding at the time of gluten introduction was associated with a reduced risk of developing celiac disease (OR 0.48, 95% CI 0.4-0.59). In addition, 1 prospective observational study, using positive celiac serology as a surrogate for diagnosis of celiac disease, reported that early introduction of gluten ( ≤ 3 months of age) as well as late introduction of gluten ( ≥ 7 months of age) are associated with an increased risk of having celiac disease in childhood [23] . A systematic review of evidence accumulated until 2012 indicated that 'In the absence of clear evidence, it is reasonable to avoid both early (<4 months) and late (>7 months) introduction of gluten and to introduce gluten while the infant is still being breastfed' [24] .
Since 2012, a plethora of evidence arising from observational and intervention studies was published, including 2 randomized controlled trials. In one of these, the PreventCD (European multicenter project Prevent Celiac Disease), infants at high risk were randomized to the introduction of gluten at the age of 4 or 6 months, preferably when still being breastfed, in a prospective doubleblind placebo-controlled design. Although not the primary outcome of the study, breastfeeding did not significantly influence the development of celiac disease [25] . The second intervention trial, the Risk of Celiac Disease and Age at Gluten Introduction (CELIPREV) trial, studied the introduction of gluten at the age of 6 versus 12 months. Again, the effect of breastfeeding was not the primary outcome of that study; nevertheless, in that study, breastfeeding duration was similar for children who developed celiac disease and those who did not [26] . A systematic review and meta-analysis of the evidence relating breastfeeding to the risk of developing celiac disease, done by the same group that summarized the data in 2012, pooled the results of 5 additional observational studies and found no significant effect of breastfeeding on the risk of developing celiac disease during childhood (OR.69, 95% CI 0.3-1.59) [27] . Furthermore, both intervention trials did not find an effect of breastfeeding at the time of gluten introduction on the risk of developing celiac disease [25, 26] . In the 2015 systematic review and meta-analysis, pooling the results of 7 observational studies demonstrated no effect of breastfeeding at the time of gluten introduction on the risk of developing celiac disease (OR 0.88, 95% CI 0.52-1.51) [27] .
Closing Remarks
One should be cautious in interpreting evidence that is based on observational cohorts and intervention studies where breastfeeding effects were not the primary outcome. Furthermore, the only intervention study, PROBIT, where breastfeeding effects were the primary outcome measured, was not able to reveal positive effects on many chronic diseases due to the lack of power to detect differences. These include the effect of breastfeeding on autoimmune disorders as well as other diseases where observational studies demonstrated an effect, such as cancer, sudden infant death syndrome as well as other diseases listed in table 1 , which were not included in this review due to space limitations.
Human milk and breastfeeding are the preferred food and feeding method for infants, with added value in premature infants, a topic (premature infants) beyond the scope of this review. Thus, one should look at the whole spectrum of benefits, proven and nonproven health outcome measures as well as other advantages (for example psychological), recognize the limitations of research on breastfeeding, and continue to protect, promote and support breastfeeding [28] .
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